Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4065 - 4072 of 11616 results
COVID-19 is Now a Pandemic – Should this Change Employers’ Response Strategies?
March 12, 2020| Blog| Viewpoint
Coronavirus Also Impacts Employee Mental Health
March 12, 2020| Blog| Viewpoint
The VALID Act, Aiming to Reform the Regulation of Diagnostic Products, Is Finally Introduced in Congress
March 12, 2020| Blog| Viewpoint
United States Bans Travelers from Europe
March 12, 2020| Alert| Viewpoint
Teleworking and the COVID-19 Outbreak
March 12, 2020| Blog| Viewpoint
In Response to COVID-19, IRS Provides High Deductible Health Plan Relief
March 12, 2020| Blog| Viewpoint
COVID-19 Legislative Update - What Will Happen Between Now and July 31, 2020?
March 12, 2020| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.